Skip to main content
Figure 6 | Diabetology & Metabolic Syndrome

Figure 6

From: Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats

Figure 6

Impact of timed daily bromocriptine or vehicle administration on pro-inflammatory regulators – NFκBp65 (Panel A), IKKαβ (Panel B), SOCS3 (Panel C), and JNK (Panel D). Proteins we quantified by Western blotting. Values are means ± SEM of 8 animals in each group. *Difference is statistically significant; P values are noted under each panel.

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us